Amgen, Watson will develop follow-on biologics for cancer

12/19/2011 | Wall Street Journal, The

Amgen will team up with Watson Pharmaceuticals to develop and commercialize follow-on versions of several antibody biotech drugs for cancer, excluding Amgen's products. Amgen will be in charge of development, production and initial marketing. Watson will provide as much as $400 million for product development and contribute its commercialization and marketing know-how.

View Full Article in:

Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice President, Science and Regulatory Affairs
American Beverage Association
Washington, DC
Senior Manager of Medical Management
Network Health
Medford, MA
MEDICAL SCIENCE LIAISON - 14000002RO
Abbott
Columbus, OH
Manager, Medical Management
Network Health
Medford, MA
Executive Medical Director
Aspirus Network Inc
Wausau, WI